A detailed history of Mather Group, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mather Group, Llc. holds 6,987 shares of LLY stock, worth $5.34 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,987
Previous 7,259 3.75%
Holding current value
$5.34 Million
Previous $6.57 Million 5.81%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$772.14 - $960.02 $210,022 - $261,125
-272 Reduced 3.75%
6,987 $6.19 Million
Q2 2024

Jul 08, 2024

SELL
$724.87 - $909.04 $105,106 - $131,810
-145 Reduced 1.96%
7,259 $6.57 Million
Q1 2024

Apr 08, 2024

BUY
$592.2 - $792.28 $1,184 - $1,584
2 Added 0.03%
7,404 $5.76 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $147,053 - $173,356
-280 Reduced 3.64%
7,402 $4.31 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $242,562 - $334,409
-558 Reduced 6.77%
7,682 $4.13 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $230,436 - $308,119
657 Added 8.66%
8,240 $3.86 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $743,958 - $873,743
2,395 Added 46.16%
7,583 $2.6 Million
Q4 2022

Mar 10, 2023

BUY
$321.55 - $374.67 $189,071 - $220,305
588 Added 12.78%
5,188 $1.9 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $12,748 - $14,528
-43 Reduced 0.93%
4,600 $1.49 Million
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $139,365 - $163,635
500 Added 12.07%
4,643 $1.51 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $446,380 - $554,737
-1,902 Reduced 31.46%
4,143 $1.19 Million
Q4 2021

Feb 15, 2022

BUY
$224.85 - $279.04 $249,358 - $309,455
1,109 Added 22.47%
6,045 $1.67 Million
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $85,316 - $104,993
385 Added 8.46%
4,936 $1.14 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $336,364 - $435,085
1,863 Added 69.31%
4,551 $1.05 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $441,692 - $571,791
2,688 New
2,688 $502,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.